NCT01222624View on ClinicalTrials.gov

PankoMab-GEX™: Phase 1 Dose Escalation Study

PHASE1CompletedINTERVENTIONAL

Enrollment

74

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

December 31, 2012

Study Completion Date

May 31, 2013

Conditions

Solid Tumors

Interventions

DRUG

PankoMab-GEX™

Trial Locations (4)

20132

Glycotope Investigational Site, Milan

20133

Glycotope Investigational Site, Milan

D-20246

Glycotope Investigational Site, Hamburg

CH-6500

Glycotope Investigational Site, Bellinzona

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Glycotope GmbH

INDUSTRY